Ptc Therapeutics, Inc.

Ownership Transactions Reported by 20 Insiders

Symbol
PTCT on Nasdaq
Industry
Pharmaceutical Preparations
Location
500 Warren Corporate Center Drive, Warren, NJ

Insiders trading volume in the past year

Ptc Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Stuart Walter Peltz CHIEF EXECUTIVE OFFICER, Director $10.9M Jan 31, 2023
Matthew B. Klein CHIEF EXECUTIVE OFFICER, Director $10.4M -$613K -5.59% Apr 19, 2024
Michael Schmertzler Director $3.9M -$41.7K -1.06% Feb 15, 2024
Neil Gregory Almstead Chief Technical Ops Officer $3.76M -$102K -2.63% Feb 15, 2024
Mark Elliott Boulding Exec. Vp And Clo $3.73M -$120K -3.1% Feb 15, 2024
Lee Scott Golden Evp & Chief Medical Officer $3.32M -$78.4K -2.31% May 7, 2024
Eric Pauwels CHIEF EXECUTIVE OFFICER, Director $3.19M -$135K -4.05% Apr 17, 2024
Pierre Gravier Chief Financial Officer $3.11M +$122K +4.07% Jul 16, 2024
Christine Marie Utter Svp, Chief Accounting Officer $2.38M -$90.7K -3.68% Feb 15, 2024
Emily Luisa Hill Chief Financial Officer $1.07M Mar 27, 2023
Dawn Svoronos Director $794K Jun 9, 2022
David P. Southwell Director $746K May 8, 2024
Allan Steven Jacobson Director $716K -$274K -27.7% Feb 15, 2024
Glenn Jr Steele Director $666K Feb 15, 2024
Mary L. Smith Director $647K Feb 15, 2024
Alethia Young Director $627K Feb 15, 2024
Emma Reeve Director $576K Feb 15, 2024
Jerome B. Zeldis Director $554K -$765K -58% May 22, 2024
William F. Bell Jr. Director $552K Feb 15, 2024
Stephanie Okey Director $539K Feb 15, 2024

Recent Insider Transactions by Companies or Individuals for Ptc Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.